does allulose stimulate glp-1 GLP-1: Genetic Variants Related to RA Medications Is Allulose a GLP-1 Agonist?

A large Cleveland Clinic study has found that people with obesity and Type 2 diabetes who undergo weight-loss surgery live longer and face fewer serious health problems compared with those treated with GLP-1 receptor agonist medicines alone.

To evaluate the cardiovascular outcomes of glucagonlike peptide1 receptor agonists (GLP1RA) in patients with type 2 diabetes (T2DM) and chronic kidney disease (CKD)

Strengths Acts via multiple pathways (GLP-1, AMPK, microbiome) Has existing human data showing reductions in fasting glucose, HbA1c, lipids Support receptor expression and islet health Limitations Low absorption and bioavailability Gastrointestinal discomfort is common (diarrhea, cramping)

For so many people, years of frustration can make sustainable weight loss feel out of reach

The tennis star says shes lost 31 pounds on a weight-loss drug.

The growing popularity of GLP-1 receptor agonistsincluding Ozempic and Wegovy from Novo Nordisk, and Mounjaro and Zepbound from Eli Lillyhas added fuel to an already fiery debate over the governments